Haemonetics Corporation (HAE)
USD 78.77
(-4.02%)
USD 78.77
(-4.02%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 262.09 Million USD | 6.51% |
| 2023 | 249.34 Million USD | 47.13% |
| 2022 | 178.49 Million USD | 19.14% |
| 2021 | 142.25 Million USD | -46.17% |
| 2020 | 264.23 Million USD | 36.94% |
| 2019 | 192.96 Million USD | 32.71% |
| 2018 | 153.03 Million USD | 12.76% |
| 2017 | 70.35 Million USD | 2.04% |
| 2016 | 45.96 Million USD | 211.72% |
| 2015 | 125.71 Million USD | -14.34% |
| 2014 | 127.04 Million USD | -22.01% |
| 2013 | 124.57 Million USD | -28.49% |
| 2012 | 139.46 Million USD | -46.66% |
| 2011 | 158.23 Million USD | 63.96% |
| 2010 | 125.24 Million USD | -21.76% |
| 2009 | 121.52 Million USD | 24.61% |
| 2008 | 101.48 Million USD | -0.43% |
| 2007 | 101.09 Million USD | 5.2% |
| 2006 | 124.16 Million USD | 8.7% |
| 2005 | 87.51 Million USD | 16.47% |
| 2004 | 77.44 Million USD | 18.17% |
| 2003 | 65.91 Million USD | -20.63% |
| 2002 | 72.06 Million USD | -20.95% |
| 2001 | 81.02 Million USD | 54.58% |
| 2000 | 73.12 Million USD | 27.88% |
| 1999 | 51.2 Million USD | -33.42% |
| 1998 | 53.9 Million USD | 35.63% |
| 1997 | 72 Million USD | -11.68% |
| 1996 | 67.4 Million USD | 0.16% |
| 1995 | 66.1 Million USD | 7.19% |
| 1994 | 62.5 Million USD | 19.36% |
| 1993 | 50.3 Million USD | 38.02% |
| 1992 | 36.9 Million USD | -76.92% |
| 1991 | 157.3 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 52.94 Million USD | -53.97% |
| 2024 Q4 | 78.8 Million USD | 13.37% |
| 2024 Q3 | 69.5 Million USD | 96.89% |
| 2024 FY | - USD | 22.46% |
| 2024 Q1 | 76.69 Million USD | 29.75% |
| 2023 Q1 | 53.21 Million USD | 70.23% |
| 2023 Q2 | 69.78 Million USD | 31.14% |
| 2023 Q3 | 66.84 Million USD | -4.21% |
| 2023 Q4 | 59.1 Million USD | -11.58% |
| 2023 FY | - USD | 47.13% |
| 2022 Q4 | 31.26 Million USD | -47.92% |
| 2022 FY | - USD | 19.14% |
| 2022 Q2 | 48.04 Million USD | 565.71% |
| 2022 Q3 | 60.01 Million USD | 24.92% |
| 2022 Q1 | 7.21 Million USD | 1246.46% |
| 2021 Q3 | 39.31 Million USD | -18.38% |
| 2021 Q1 | 33.46 Million USD | -38.9% |
| 2021 Q2 | 48.16 Million USD | 43.91% |
| 2021 FY | - USD | -46.17% |
| 2021 Q4 | 536 Thousand USD | -98.64% |
| 2020 Q3 | 69.83 Million USD | 40.41% |
| 2020 Q2 | 49.73 Million USD | -20.87% |
| 2020 Q4 | 54.77 Million USD | -21.57% |
| 2020 FY | - USD | 36.94% |
| 2020 Q1 | 62.85 Million USD | 17.19% |
| 2019 Q2 | 51.35 Million USD | 61.96% |
| 2019 Q4 | 53.63 Million USD | -4.67% |
| 2019 Q3 | 56.26 Million USD | 9.57% |
| 2019 Q1 | 31.7 Million USD | 122.12% |
| 2019 FY | - USD | 32.71% |
| 2018 Q2 | 46.45 Million USD | 20.98% |
| 2018 FY | - USD | 12.76% |
| 2018 Q4 | 14.27 Million USD | -38.72% |
| 2018 Q1 | 38.4 Million USD | 13029.29% |
| 2018 Q3 | 23.29 Million USD | -49.86% |
| 2017 Q1 | 14.66 Million USD | -12.31% |
| 2017 FY | - USD | 2.04% |
| 2017 Q2 | 47.5 Million USD | 223.97% |
| 2017 Q4 | -297 Thousand USD | -100.68% |
| 2017 Q3 | 43.93 Million USD | -7.5% |
| 2016 Q3 | 18.97 Million USD | -54.74% |
| 2016 FY | - USD | 211.72% |
| 2016 Q1 | 25.86 Million USD | 124.14% |
| 2016 Q4 | 16.72 Million USD | -11.87% |
| 2016 Q2 | 41.92 Million USD | 62.11% |
| 2015 Q1 | -1.66 Million USD | -113.17% |
| 2015 Q4 | 11.53 Million USD | -36.81% |
| 2015 Q3 | 18.26 Million USD | 47.17% |
| 2015 FY | - USD | -14.34% |
| 2015 Q2 | 12.4 Million USD | 844.72% |
| 2014 Q1 | -6.6 Million USD | -137.32% |
| 2014 FY | - USD | -22.01% |
| 2014 Q3 | 17.86 Million USD | -23.77% |
| 2014 Q2 | 23.43 Million USD | 454.57% |
| 2014 Q4 | 12.64 Million USD | -29.19% |
| 2013 Q3 | 15.74 Million USD | 40.45% |
| 2013 Q2 | 11.21 Million USD | -12.01% |
| 2013 Q1 | 12.74 Million USD | -62.56% |
| 2013 FY | - USD | -28.49% |
| 2013 Q4 | 17.7 Million USD | 12.45% |
| 2012 Q2 | 17.73 Million USD | -26.15% |
| 2012 Q3 | 37.82 Million USD | 113.25% |
| 2012 Q4 | 34.04 Million USD | -9.99% |
| 2012 Q1 | 24.01 Million USD | -42.54% |
| 2012 FY | - USD | -46.66% |
| 2011 Q3 | 28.55 Million USD | 3.84% |
| 2011 Q1 | 24.29 Million USD | -16.19% |
| 2011 Q2 | 27.5 Million USD | 13.23% |
| 2011 FY | - USD | 63.96% |
| 2011 Q4 | 41.79 Million USD | 46.34% |
| 2010 Q2 | 27.12 Million USD | 2.42% |
| 2010 Q1 | 26.48 Million USD | 8.74% |
| 2010 FY | - USD | -21.76% |
| 2010 Q4 | 28.98 Million USD | 11.94% |
| 2010 Q3 | 25.89 Million USD | -4.55% |
| 2009 Q3 | 37.7 Million USD | 7.73% |
| 2009 Q2 | 34.99 Million USD | 29.88% |
| 2009 Q4 | 24.35 Million USD | -35.4% |
| 2009 Q1 | 26.94 Million USD | -7.17% |
| 2009 FY | - USD | 24.61% |
| 2008 FY | - USD | -0.43% |
| 2008 Q4 | 29.02 Million USD | 7.17% |
| 2008 Q3 | 27.08 Million USD | 26.62% |
| 2008 Q1 | 22 Million USD | -13.43% |
| 2008 Q2 | 21.39 Million USD | -2.78% |
| 2007 Q1 | 20.87 Million USD | -62.81% |
| 2007 FY | - USD | 5.2% |
| 2007 Q4 | 25.41 Million USD | 10.05% |
| 2007 Q3 | 23.09 Million USD | -24.03% |
| 2007 Q2 | 30.4 Million USD | 45.64% |
| 2006 Q2 | 21.85 Million USD | -4.83% |
| 2006 Q1 | 22.96 Million USD | 2.24% |
| 2006 FY | - USD | 8.7% |
| 2006 Q4 | 56.12 Million USD | 1045.45% |
| 2006 Q3 | -5.93 Million USD | -127.16% |
| 2005 Q2 | 21.14 Million USD | -5.4% |
| 2005 FY | - USD | 16.47% |
| 2005 Q1 | 22.35 Million USD | 4.68% |
| 2005 Q3 | 21.43 Million USD | 1.35% |
| 2005 Q4 | 22.45 Million USD | 4.78% |
| 2004 FY | - USD | 18.17% |
| 2004 Q2 | 16.66 Million USD | 6.35% |
| 2004 Q4 | 21.35 Million USD | 0.03% |
| 2004 Q1 | 15.66 Million USD | 34.72% |
| 2004 Q3 | 21.34 Million USD | 28.12% |
| 2003 Q4 | 12.4 Million USD | -39.39% |
| 2003 FY | - USD | -20.63% |
| 2003 Q3 | 19.73 Million USD | 16.36% |
| 2003 Q2 | 17.01 Million USD | 1.83% |
| 2003 Q1 | 16.75 Million USD | -57.02% |
| 2002 FY | - USD | -20.95% |
| 2002 Q2 | 22.6 Million USD | -30.94% |
| 2002 Q1 | 32.6 Million USD | -9.21% |
| 2002 Q3 | 6.54 Million USD | -72.16% |
| 2002 Q4 | 27.54 Million USD | 519.48% |
| 2001 FY | - USD | 54.58% |
| 2001 Q1 | 14.31 Million USD | -34.91% |
| 2001 Q2 | 14.23 Million USD | 167.13% |
| 2001 Q3 | 17 Million USD | -55.8% |
| 2001 Q4 | 35.37 Million USD | 117.22% |
| 2000 Q3 | 14.3 Million USD | -11.04% |
| 2000 FY | - USD | 27.88% |
| 2000 Q4 | 12.33 Million USD | 52.37% |
| 2000 Q1 | 15.9 Million USD | 30.36% |
| 2000 Q2 | 16.1 Million USD | 5.48% |
| 1999 Q1 | 12.4 Million USD | -52.42% |
| 1999 FY | - USD | -33.42% |
| 1999 Q4 | 12.5 Million USD | -15.15% |
| 1999 Q3 | 14.4 Million USD | -7.04% |
| 1999 Q2 | 17.2 Million USD | 10.94% |
| 1998 Q4 | 26.2 Million USD | 6.32% |
| 1998 FY | - USD | 35.63% |
| 1998 Q1 | 14.9 Million USD | 21.93% |
| 1998 Q2 | 15.1 Million USD | -22.3% |
| 1998 Q3 | 14.6 Million USD | 134.26% |
| 1997 Q1 | 17.4 Million USD | 26.19% |
| 1997 Q4 | 12.9 Million USD | -16.18% |
| 1997 Q3 | 14.5 Million USD | -13.38% |
| 1997 Q2 | 16.6 Million USD | -1.26% |
| 1997 FY | - USD | -11.68% |
| 1996 Q2 | 17.9 Million USD | -1.75% |
| 1996 Q1 | 17.7 Million USD | 8.92% |
| 1996 Q3 | 18.1 Million USD | 4.76% |
| 1996 FY | - USD | 0.16% |
| 1996 Q4 | 13.7 Million USD | -28.41% |
| 1995 Q4 | 15.9 Million USD | -2.48% |
| 1995 Q1 | 16.3 Million USD | 8.39% |
| 1995 Q2 | 17.4 Million USD | 8.39% |
| 1995 Q3 | 16.7 Million USD | -4.17% |
| 1995 FY | - USD | 7.19% |
| 1994 Q2 | 16.1 Million USD | 17.16% |
| 1994 Q1 | 13.8 Million USD | 0.75% |
| 1994 FY | - USD | 19.36% |
| 1994 Q4 | 16.2 Million USD | -12.8% |
| 1994 Q3 | 16.4 Million USD | 4.46% |
| 1993 Q3 | 13.6 Million USD | 11.38% |
| 1993 Q4 | 13.4 Million USD | -2.92% |
| 1993 FY | - USD | 38.02% |
| 1993 Q1 | 11 Million USD | 5.83% |
| 1993 Q2 | 12.5 Million USD | 12.84% |
| 1992 Q3 | 9.6 Million USD | 11.63% |
| 1992 Q4 | 10.5 Million USD | 7.29% |
| 1992 Q2 | 8.9 Million USD | 13.16% |
| 1992 FY | - USD | -76.92% |
| 1992 Q1 | 7.8 Million USD | -80.71% |
| 1991 Q2 | 39.3 Million USD | 0.0% |
| 1991 Q1 | 39.3 Million USD | 0.0% |
| 1991 Q3 | 39.3 Million USD | 0.0% |
| 1991 Q4 | 39.4 Million USD | 0.25% |
| 1991 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alcon Inc. | 2.39 Billion USD | 89.047% |
| AptarGroup, Inc. | 663.83 Million USD | 60.518% |
| Baxter International Inc. | 2.77 Billion USD | 90.558% |
| Becton, Dickinson and Company | 2.42 Billion USD | 89.192% |
| Bausch + Lomb Corporation | 586 Million USD | 55.273% |
| Envista Holdings Corp | 171.1 Million USD | -53.184% |
| ResMed Inc. | 1.6 Billion USD | 83.622% |
| Teleflex Incorporated | 792.26 Million USD | 66.918% |
| Warby Parker Inc. | -30.21 Million USD | 967.529% |
| West Pharmaceutical Services, Inc. | 847.8 Million USD | 69.085% |